Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I

New England Journal of Medicine

Volumn 355, Issue 26, 2006, Pages 2752-2756

  Vanhollebeke, Benoit ^a   Truc, Philippe ^b   Poelvoorde, Philippe ^a   Pays, Annette ^a   Joshi, Prashant P ^c   Katti, Ravindra ^d   Jannin, Jean G ^e   Pays, Etienne ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c GOVERNMENT MEDICAL COLLEGE   (India)

^d Directorate of Health Services   (India)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; HUMAN; INDIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA EVANSI;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS; FRAMESHIFT MUTATION; HUMANS; LIPOPROTEINS, HDL; MALE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; TRYPANOSOMA; TRYPANOSOMIASIS;

EID: 33845868544     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa063265     Document Type: Article

References (13)

1. Laveran A, Mesnil F. Trypanosomes et trypanosomiases. Paris: Masson et Cie, 1912:379.
2. Hawking F. The resistance of Trypanosoma congolense, T. vivax and T. evansi to human plasma. Trans R Soc Trop Med Hyg 1978;72:405-7.
3. Juyal PD, Singla LD, Saxena HM. In vivo activity of human serum against T. evansi infection in Swiss albino mice. J Parasitic Dis India 1998;22:67-8.
4. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003;422:83-7.
5. Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 2005;309:469-72.
6. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Pérez-Morga D. The trypanolytic factor of human serum. Nat Rev Microbiol 2006;4:477-86.
7. Xong HV, Vanhamme L, Chamekh M, et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 1998;95:839-46.
8. Gibson WC. The SRA gene: the key to understanding the nature of Trypanosoma brucei rhodesiense. Parasitology 2005;131:143-50.
9. Joshi PP, Shegokar VR, Powar RM, et al. Human trypanosomiasis caused by Trypanosoma evansi in India: the first case report. Am J Trop Med Hyg 2005;73:491-5.
10. Joshi PP, Chaudhari A, Shegokar VR, et al. Treatment and follow-up of the first case of human trypanosomiasis caused by Trypanosoma evansi in India. Trans R Soc Trop Med Hyg 2006;100:989-91.
11. Truc P, Gibson WC, Herder S. Genetic characterization of Trypanosoma evansi isolated from a patient in India. Infect Genet Evol (in press).
12. Hirumi H, Hirumi K. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 1989;75:985-9.
13. Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC. Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci U S A 1997;94:5113-8.